(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Electronics
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > Pharmaceuticals & Biotechnology
 
 
Animal Health - 137
Biotechnology - 35
Ethical Pharmaceuticals - 143
Healthcare - 14
Medical Equipment - 58
Pharmaceutical Intermediates - 10
 
 Pharmaceuticals & Biotechnology Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  3  4  5  6  7  8  9  10  11  12  Next »
PharmaFocus: Market Access Strategies for Antibiotics Targeting Multidrug-Resistant Gram-Negative Bacteria

Since their discovery almost a century ago, antibiotics have revolutionized the global healthcare industry by ushering in an era of significantly reduced morbidity and mortality associated with often-lethal bacterial infections. However, the increasing threat posed by multidrug-resistant (MDR) bacteria, in particular gram-negative organisms, has cast a shadow over these remarkable public health achievements....

 

$3995.00
       
EpiCast Report: Atopic Dermatitis - Epidemiology Forecast to 2022

Atopic dermatitis or atopic eczema is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Though the condition affects people of all ages, it is primarily common among infants and children (Bowcock and Cookson, 2004)....

 

$3995.00
       
PharmaFocus: HIV - R&D Strategies towards Cure and Prevention

It has been 30 years since the discovery that HIV is the causative agent of AIDS, and yet no preventative vaccine or cure that allows independence from lifelong antiretroviral treatment exists. Despite some recent setbacks, such as the discontinuation of the HVTN 505 clinical trial due to a trend of increased infection, there have been several promising advances in the cure and prevention of HIV infections.

 

$3995.00
       
EpiCast Report: Endometriosis - Epidemiology Forecast to 2022

Endometriosis is an estrogen-dependent disorder characterized by growth and appearance of endometrial cells or tissues in locations outside the uterus, which results in a series of chronic inflammatory reactions leading to scarring of tissues and adhesions of fibrous tissues in the pelvic region. Globally, the disease affects up to 10% of women....

 

$3995.00
       
EpiCast Report: Gram-Negative Bacterial Pneumonia - Epidemiology Forecast to 2022

Pneumonia is one of the most common infectious diseases and a major public health concern in both developed and developing countries (Farr et al., 2000)....

 

$3995.00
       
Drug Reconstitution at the Point of Care

Greystone Research Associates is pleased to announce the publication of a new market study. Point-of-Delivery Reconstitution Systems: Therapeutic Markets, Technology, Strategies and Prospects is a comprehensive evaluation and analysis of the technology, devices and participants behind the innovative approaches that address the growing need for packaging and delivering lyophilized drugs for injection....

 

$3850.00
       
APTT: US, Europe, Japan
Test Volume Forecasts by Country and Market Segment through 2018


The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....

 

$3850.00
       
Alpha-2 Antiplasmin: US, Europe, Japan
Test Volume Forecasts by Country and Market Segment through 2018


The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....

 

$3850.00
       
Antithrombin III: US, Europe, Japan
Test Volume Forecasts by Country and Market Segment through 2018


The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....

 

$3850.00
       
D-Dimer: US, Europe, Japan
Test Volume Forecasts by Country and Market Segment through 2018


The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....

 

$3850.00
       
Fibrinogen: US, Europe, Japan
Test Volume Forecasts by Country and Market Segment through 2018


The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....

 

$3850.00
       
Heparin: US, Europe, Japan
Test Volume Forecasts by Country and Market Segment through 2018


The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....

 

$3850.00
       
Proteins C and S: US, Europe, Japan
Test Volume Forecasts by Country and Market Segment through 2018


The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....

 

$3850.00
       
PT Testing: US, Europe, Japan
Test Volume Forecasts by Country and Market Segment through 2018


The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....

 

$3850.00
       
Thrombin Time: US, Europe, Japan
Test Volume Forecasts by Country and Market Segment through 2018


The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....

 

$3850.00
       
Emerging Infectious Disease Tests and Companies Developing New Technologies and Products

The report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for nearly 80 infectious diseases and viruses, including their scientific background, clinical significance and market needs for both current and emerging tests, vaccines, drugs and extensive listings of companies developing or marketing new technologies and products.

Contains 650 pages and 47 tables



 

$3850.00
       
Adenovirus Diagnostics Market: US, Europe, Japan
Test Volume, Sales Forecasts and Supplier Shares by Country


The report presents a detailed analysis of the Adenovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Adenovirus definition, epidemiology and etiology are reviewed....

 

$3850.00
       
Aeromonads Diagnostics Market: US, Europe, Japan
Test Volume and Sales Forecasts by Country


The report presents a detailed analysis of the Aeromonads diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Aeromonads definition, epidemiology and etiology are reviewed....

 

$3850.00
       
« Previous     3  4  5  6  7  8  9  10  11  12   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X